Table 3.
Study | All | Wilson | Wilson Bonferroni | Clopper-Pearson | Clopper- Pearson Bonferroni | Hotelling | Hotelling Continuity |
---|---|---|---|---|---|---|---|
Arroll | Include | Include | Include | Include | Include | Include | Include |
Ayalon | Include | ||||||
Azah | Include | Include | Include | Include | Include | Include | Include |
Cheng | Include | Include | Include | Include | Include | Include | Include |
Zuithoff | Include | ||||||
Gilbody | Include | Include | Include | Include | Include | Include | Include |
Lotrakul | Include | Include | Include | Include | Include | Include | Include |
Inagaki | Include | ||||||
Liu | Include | Include | Include | Include | |||
Sherina | Include | Include | Include | Include | Include | Include | Include |
Sensitivity (95% CI) | 74.2% (63.2-82.8) | 78.8% (69.7-85.7) | 78.8% (69.7-85.7) | 78.8% (69.7-85.7) | 79.7% (71.6-86.0) | 79.7% (71.6-86.0) | 79.7% (71.6-86.0) |
Specificity (95% CI) | 91.5% (86.5-94.8) | 86.3% (81.4-90.1) | 86.3% (81.4-90.1) | 86.3% (81.4-90.1) | 87.9% (83.1-91.5) | 87.9% (83.1-91.5) | 87.9% (83.1-91.5) |